Technology | October 05, 2008

SURE Cardio Prospective Helps Reduce Radiation Dose

Automated workflow enhancements and clinical applications for the Aquilion CT line are designed to reduce patient radiation dose, provide faster diagnosis and maximize patient comfort.

An example of two applications that will be showcased include SURE Cardio Prospective and Variable Helical Pitch (vHP). Toshiba’s SURECardio Prospective helps reduce patient radiation dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot technique. The step-and-shoot technique can produce inconclusive images, particularly for patients with irregular heartbeats, leading to increased exam times and radiation dose for the patient. SURECardio Prospective will automatically adjust to patients with irregular heartbeats, providing quicker, more conclusive exam results.

SURECardio Prospective automates scan parameters and reconstruction based on the patient’s heart rate. It also speeds exam time and eliminates the need for additional contrast used with the step-and-shoot method.

Variable Helical Pitch (vHP) increases workflow and efficiency by enabling physicians to complete an exam of more than one anatomical region consecutively (i.e. without stopping to alter the helical pitch of the exam.) This gives physicians the flexibility needed for cardiovascular imaging, the company said. For example, patients with suspected chest pain can now undergo one CT exam that provides physicians information to assist in the diagnosis of both heart disease and aortic aneurysms.

Toshiba said it is the first to clinically introduce this type of technique.

October 2008


Related Content

News | CT Angiography (CTA)

Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...

Home October 30, 2025
Home
News | CT Angiography (CTA)

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Home October 29, 2025
Home
News | CT Angiography (CTA)

Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...

Home October 23, 2025
Home
News | CT Angiography (CTA)

Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 09, 2025
Home
News | CT Angiography (CTA)

Aug. 11, 2025 — Elucid announced that United Healthcare has updated its cardiac imaging guidelines to align with recent ...

Home August 11, 2025
Home
News | CT Angiography (CTA)

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Home May 02, 2025
Home
News | CT Angiography (CTA)

May 1, 2025 — A new expert opinion document jointly released by the Society for Cardiovascular Angiography and ...

Home May 01, 2025
Home
Feature | CT Angiography (CTA) | By Melinda Taschetta-Millane

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

Home March 07, 2024
Home
News | CT Angiography (CTA)

January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...

Home January 23, 2024
Home
News | CT Angiography (CTA)

January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with ...

Home January 11, 2024
Home
Subscribe Now